Budget Amount *help |
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2017: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2016: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2015: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Outline of Final Research Achievements |
We tried to establish for prediction of DiabetesMellitus by using with iPS cell technology and novel therapeutic strategy with stem cells. We could isolated iPS cells originated from healthy control and type 1 Diabetes Mellitus, which were differentiated into beta cells. We could establish the way to purify the insulin producing cells and expansion methods with these iPS cells. We could also establish the method of mass culture suitable to clinical therapy. In addition, we analyzed metabolome investigation in beta cells differentiated from iPS cells and it is indicated that mitochondrial dysfunction may influence type 1 diabetes.
|